SCHEMBL51956

SCHEMBL51956

O=C(NCc1ccc(F)cc1)c1nc2n(c(=O)c1O)CC1CCC2(N(Cc2ccccc2)C(=O)O)CO1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.45
CYP2C9 P11712 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
ERCC1 P07992 1/20 0.37
FEN1 P39748 1/20 0.37
ERCC4 Q92889 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KCNE1 P15382 1/20 0.36
CCR1 P32246 1/20 0.36
KCNQ1 P51787 1/20 0.36
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TRPA1 O75762 1/20 0.35
CALCA P06881 1/20 0.35
AADAT Q8N5Z0 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422140 0.89 KCNH2 (0.50) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52492 0.88 KCNH2 (0.46) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL417695 0.85 CYP2C9 (0.52) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL10143669 0.84 CYP2C9 (0.54) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL10143829 0.84 CYP2C9 (0.51) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL2634243 0.83 KCNH2 (0.46) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52281 0.82 KCNH2 (0.43) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL10144300 0.82 KCNH2 (0.49) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL52381 0.82 KCNH2 (0.48) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1
SCHEMBL10144462 0.82 KCNH2 (0.48) KCNH2CYP2C9SMN1; SMN2L3MBTL1ERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280981-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-02-09 EP disclosed